Clinical Trial Update: Effect of Selenium Supplementation on Inflammatory,Oxidative and Nutritional Markers in Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating selenium supplementation and its impact on inflammatory, oxidative, and nutritional markers in hemodialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Complications of Hemodialysis
• End-stage Renal Disease
• Inflammation
• Malnutrition

Drugs mentioned

• Selenium supplement (selenium)

Snippet

Sponsor: Zahra Sohrabi | Conditions: Inflammation, Malnutrition | Phase 3 | Status: COMPLETED